J.Safra Asset Management »

Celldex Therapeutics shares owned by J.Safra Asset Management

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by J.Safra Asset Management from 13F filings

Historical chart of J.Safra Asset Management investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by J.Safra Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by J.Safra Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.0k 40 25.88
2025-06-30 $4.8k 235 20.35
2025-03-31 $6.0k 330 18.15
2024-12-31 $7.8k 312 25.12
2024-09-30 $6.1k 183 33.20
2024-06-30 $925 25 37.00